These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35524809)

  • 1. Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid.
    Cheng L; Yao P; Weng B; Yang M; Wang Q
    Eur J Clin Pharmacol; 2022 Aug; 78(8):1227-1238. PubMed ID: 35524809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant.
    Ciftci HS; Demir E; Karadeniz MS; Tefik T; Nane I; Oguz FS; Aydin F; Turkmen A
    Ren Fail; 2018 Nov; 40(1):395-402. PubMed ID: 30012031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation.
    Kagaya H; Miura M; Saito M; Habuchi T; Satoh S
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):631-6. PubMed ID: 20136638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.
    Baldelli S; Merlini S; Perico N; Nicastri A; Cortinovis M; Gotti E; Remuzzi G; Cattaneo D
    Pharmacogenomics; 2007 Sep; 8(9):1127-41. PubMed ID: 17924828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil.
    Cilião HL; Camargo-Godoy RBO; Souza MF; Zanuto A; Delfino VDA; Cólus IMS
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):97-102. PubMed ID: 30442353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
    van Schaik RH; van Agteren M; de Fijter JW; Hartmann A; Schmidt J; Budde K; Kuypers D; Le Meur Y; van der Werf M; Mamelok R; van Gelder T
    Clin Pharmacol Ther; 2009 Sep; 86(3):319-27. PubMed ID: 19494809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of UDP-glucuronosyltransferase 1A9 (UGT1A9) gene polymorphism with kidney allograft function.
    Pazik J; Ołdak M; Dąbrowski M; Lewandowski Z; Sitarek E; Podgórska M; Ważna E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
    Ann Transplant; 2011; 16(4):69-73. PubMed ID: 22210424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.
    Wang J; Yang JW; Zeevi A; Webber SA; Girnita DM; Selby R; Fu J; Shah T; Pravica V; Hutchinson IV; Burckart GJ
    Clin Pharmacol Ther; 2008 May; 83(5):711-7. PubMed ID: 17851563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
    Zhu CL; Huang Q; Liu CH; Xie F
    Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients.
    Fukuda T; Goebel J; Cox S; Maseck D; Zhang K; Sherbotie JR; Ellis EN; James LP; Ward RM; Vinks AA
    Ther Drug Monit; 2012 Dec; 34(6):671-9. PubMed ID: 23131697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Pharmacogenetic Determinants of Tacrolimus and Mycophenolate on Adverse Events in Renal Transplant Patients.
    Thishya K; Sreenu B; Raju SB; Kutala VK
    Curr Drug Metab; 2021; 22(5):342-352. PubMed ID: 33459227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient uridine 5'-diphospho-glucuronosyltransferase UGT1A9 c.98T>C variant determines transplanted kidney filtration rate.
    Pazik J; Ołdak M; Lewandowski Z; Dąbrowski M; Podgórska M; Sitarek E; Malejczyk J; Płoski R; Durlik M
    Transplant Proc; 2014 Oct; 46(8):2678-82. PubMed ID: 25380893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the association of UGT1A9 gene c.98T>C polymorphism and mycophenolic acid plasma levels in renal transplant patients.
    Ruschel LR; Schmitt VM; Silva AB; Oliveira CSA; Flach K; d'Avila DO; Thiesen FV
    Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28613375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
    Kuypers DR; Naesens M; Vermeire S; Vanrenterghem Y
    Clin Pharmacol Ther; 2005 Oct; 78(4):351-61. PubMed ID: 16198654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients.
    Woillard JB; Picard N; Thierry A; Touchard G; Marquet P;
    Pharmacogenet Genomics; 2014 May; 24(5):256-62. PubMed ID: 24681964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.
    Michelon H; König J; Durrbach A; Quteineh L; Verstuyft C; Furlan V; Ferlicot S; Letierce A; Charpentier B; Fromm MF; Becquemont L
    Pharmacogenomics; 2010 Dec; 11(12):1703-13. PubMed ID: 21142914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
    Inoue K; Miura M; Satoh S; Kagaya H; Saito M; Habuchi T; Suzuki T
    Ther Drug Monit; 2007 Jun; 29(3):299-304. PubMed ID: 17529886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism.
    Pazik J; Ołdak M; Podgórska M; Lewandowski Z; Sitarek E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
    Transplant Proc; 2011 Oct; 43(8):2943-5. PubMed ID: 21996196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of MRP2 and UGT2B7 and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.
    Yang JW; Lee PH; Hutchinson IV; Pravica V; Shah T; Min DI
    Ther Drug Monit; 2009 Oct; 31(5):542-8. PubMed ID: 19730281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1α and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.
    Vu D; Tellez-Corrales E; Yang J; Qazi Y; Shah T; Naraghi R; Hutchinson IV; Min DI
    Transpl Immunol; 2013 Dec; 29(1-4):155-61. PubMed ID: 23721685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.